| Dr Rhody D Eisenstein, MD | |
|
232 S Woods Mill Rd, Chesterfield, MO 63017-3417 | |
| (314) 205-6030 | |
| Not Available |
| Full Name | Dr Rhody D Eisenstein |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Sleep Medicine |
| Location | 232 S Woods Mill Rd, Chesterfield, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063558948 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | R2B51 (Missouri) | Secondary |
| 207RS0012X | Internal Medicine - Sleep Medicine | R2B51 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rhody D Eisenstein, MD 232 S Woods Mill Rd, Chesterfield, MO 63017-3417 Ph: (314) 205-6030 | Dr Rhody D Eisenstein, MD 232 S Woods Mill Rd, Chesterfield, MO 63017-3417 Ph: (314) 205-6030 |
News Archive
Interest has been growing in the use of cannabinoids-the active chemicals in cannabis or marijuana- for the treatment of epilepsy in children. A recent Epilepsia analysis of relevant published studies indicates that this strategy looks promising.
W. Ian Lipkin, director of the Center for Infection and Immunity and John Snow Professor of Epidemiology at the Mailman School of Public Health, has received an award of up to $31 million over a five-year period by the National Institutes of Health (NIH) to establish the Center for Research in Diagnostics and Discovery (CRDD) under the auspices of a new National Institute of Allergy and Infectious Diseases (NIAID) program entitled Centers of Excellence for Translational Research.
Today, two of the nation's leading health and fiscal policy experts discussed how to reign in rising health care costs in Medicare in light of a new Health Affairs study that shows rising Medicare costs in the nation's health care system are linked to the growth in several common costly chronic conditions, such as diabetes, arthritis, hypertension, and kidney disease.
Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.
› Verified 3 days ago
Lovepreet Singh Randhawa, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6050 Fax: 314-205-6350 | |
Rachel Lynn Fishman Oiknine, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 S Woods Mill Rd, Suite 410n, Chesterfield, MO 63017 Phone: 314-469-6224 Fax: 314-469-0744 | |
Xiaoling Wu, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 224 S Woods Mill Rd, Suite 370 South, Chesterfield, MO 63017 Phone: 314-878-2460 | |
Daniel B Bauwens, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-576-5023 | |
Michael Carl Fusco, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 14528 S Outer 40, Suite 300, Chesterfield, MO 63017 Phone: 314-214-8100 Fax: 314-214-8233 | |
David H Cort, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 226 S Woods Mill Rd, Suite 52 West, Chesterfield, MO 63017 Phone: 314-434-2399 Fax: 314-434-5653 | |
Meghashyam Jayateerth Koti, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 15740 S Outer 40 Rd # C, Chesterfield, MO 63017 Phone: 636-735-4963 |